Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “PTC THERAPEUTICS, INC.”

149 pharma patents match "PTC THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 149
Index total 30,257
Page 4 / 7

Quick answer

This filtered view shows 149 pharmaceutical patents matching "PTC THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

149 results for “PTC THERAPEUTICS, INC.” · 30,257 patents in full index Clear search

  1. US 9617268

    Compounds for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted
  2. US 9611230

    1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  3. US 9593108

    Compounds and methods for antiviral treatment

    PTC THERAPEUTICS, INC. · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  4. US 9586955

    Compounds for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  5. US 9522137

    Methods for dosing an orally active 1,2,4-Oxadiazole for nonsense mutation suppression therapy

    PTC THERAPEUTICS, INC. · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  6. US 9493845

    Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same

    PTC THERAPEUTICS, INC. · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  7. US 9474743

    Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted
  8. US 9409905

    Antibacterial compounds and methods for use

    PTC THERAPEUTICS, INC. · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  9. US 9399649

    Compounds for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted
  10. US 9371336

    Compounds for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  11. US 9351964

    Methods for treating cancer and non-neoplastic conditions

    PTC THERAPEUTICS, INC. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  12. US 9315467

    Compounds for nonsense suppression, and methods for their use

    PTC THERAPEUTICS, INC. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  13. US 9309206

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4] oxadiazol-3-yl]-benzoic acid

    PTC THERAPEUTICS, INC. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted
  14. US 9289398

    Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith

    PTC THERAPEUTICS, INC. · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted
  15. US 9273076

    Compounds for nonsense suppression, and methods for their use

    PTC THERAPEUTICS, INC. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  16. US 9271960

    Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control

    PTC THERAPEUTICS, INC. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  17. US 9226919

    Methods for dosing an orally active 1,2,4-oxadiazole

    PTC THERAPEUTICS, INC. · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  18. US 9205088

    Compositions of 1,2,4-oxadiazol benzoic acid compounds and methods for their use

    PTC THERAPEUTICS, INC. · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted
  19. US 9198907

    Combinations of a HCV inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent

    PTC THERAPEUTICS, INC. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  20. US 9051342

    Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation related diseases

    PTC THERAPEUTICS, INC. · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  21. US 8986935

    Methods for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  22. US 8975287

    Methods for using 1,2,4-Oxadiazole benzoic acid compounds

    PTC THERAPEUTICS, INC. · Granted Mar 10, 2015 · Expires Mar 5, 2035

    granted
  23. US 8946444

    Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control

    PTC THERAPEUTICS, INC. · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted
  24. US 8940896

    Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis

    PTC THERAPEUTICS, INC. · Granted Jan 27, 2015 · Expires Jan 22, 2035

    granted